Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Xbio Systems

Xbio Systems
2006 FOUNDED
OOB STATUS
Out of Business LATEST DEAL TYPE
Description

Provider of integrated drug development platform designed to support drug and device development. The company's integrated drug development platform automates workflows and provides advanced content management within a secure, web-based environment.

Formerly Known As
Neuragenix
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Business/Productivity Software
Other Industries
Biotechnology
Automation/Workflow Software
Primary Office
  • 225 Market Street
  • Suite 500
  • Harrisburg, PA 17101
  • United States

+1 (717) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Xbio Systems’s full profile, request a free trial.

Xbio Systems Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Apr-2016 00.000 Completed Out of Business
3. Convertible Debt 02-Jul-2008 00000 00.000 Completed Startup
2. Grant 23-Jun-2006 $162K $2.23M Completed Startup
1. Early Stage VC 02-Apr-2006 $2.23M $2.23M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Xbio Systems Executive Team (6)

Name Title Board
Seat
Contact
Info
Steven Godinho Board Member & Chief Executive Officer
Ken Murley Chief Financial Officer
Ivan Ruzic Ph.D Chief Operating Officer
Joe Godcharles Vice President of Services of North America
Gene Clouse Vice President, Sales of North America
You’re viewing 5 of 6 executives. Get the full list »

Xbio Systems Board Members (3)

Name Representing Role Since Contact
Info
Matthew Morgan Self Board Member 000 0000
Steven Godinho Xbio Systems Board Member & Chief Executive Officer 000 0000

1 Former Board Member

You’re viewing 2 of 3 board members. Get the full list »